Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

von Drygalski, Annette; Chowdary, Pratima; Kulkarni, Roshni; Susen, Sophie; A. Konkle, Barbara; Oldenburg, Johannes; Matino, Davide; Klamroth, Robert; C. Weyand, Angela; Jiménez‐Yuste, Víctor; Nogami, Keiji; Poloskey, Stacey; Winding, Bent; Willemze, Annemieke; Knobe, Karin

doi:10.1056/nejmoa2209226

Public

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

Published in New England Journal of Medicine • Jan 25, 2023

Authors:

Annette von Drygalski

Pratima Chowdary

Roshni Kulkarni

Abstract

BACKGROUND: Efanesoctocog alfa provides high sustained factor VIII activity by overcoming the von Willebrand factor-imposed half-life ceiling. The efficacy, safety, and pharmacokinetics of efanesoctocog alfa for prophylaxis and treatment of bleeding episodes in previously treated patients with sever...

Subject

Medicine

Interquartile range

Confidence interval

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!